How soon after transplant should I start taking Valcyte?

Valcyte/Valcyte is a prescription drug indicated for the prevention of CMV disease in high-risk kidney, heart and kidney-pancreas transplant patients. For the prevention of cytomegalovirus disease in transplant patients, adults who have received a heart or kidney-pancreas transplant, 900 mg (two tablets of 450 mg) once daily starting within 10 days after transplantation and continuing until 100 days after transplantation.

Animal studies have found that valganciclovir may cause fetal toxicity when taken by pregnant women. When administered to pregnant rabbits at doses that resulted in 2 times the human exposure (based on AUC) , valganciclovir caused fetal malformations of multiple organs. Maternal and fetal toxicity has also been observed in pregnant mice and rabbits. Therefore,valganciclovirhas the potential to cause birth defects. Female patients takingvalganciclovir and women whose male partners are takingvalganciclovir should avoid becoming pregnant. Given the potential risk to the fetus, females of reproductive potential should be advised to use effective contraception during treatment and for at least 30days following treatment with valganciclovir. Likewise, men should be advised to use condoms during valganciclovir treatment and for at least 90 days after treatment.

Valganciclovir/VansevirThe most common adverse reactions and laboratory abnormalities are diarrhea, fever, fatigue, nausea, tremor, neutropenia, anemia, leukopenia, thrombocytopenia, headache, insomnia, urinary tract infection and vomiting. The retail price of the Turkish version of the original drug in pharmacies0.45g*60tablets2more than a thousand. The retail price of original medicine in India is about 0.45g*60 tablets4 around one thousand. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.